Parathyroid Cancer — Trials

Parathyroid Cancer — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Instituto do Cancer do Estado de São Paulo
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00580320	Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma	completed	Phase 1	17	Virginia Commonwealth UniversityOTHER	1	Aug 18, 2016	clinicaltrials
NCT00004074	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu	completed	Phase 1	15	National Cancer Institute (NCI)NIH	1	Feb 28, 2013	clinicaltrials